Virginia Devonshire

1.2k total citations
11 papers, 551 citations indexed

About

Virginia Devonshire is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Virginia Devonshire has authored 11 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 6 papers in Neurology and 4 papers in Rheumatology. Recurrent topics in Virginia Devonshire's work include Multiple Sclerosis Research Studies (7 papers), Peripheral Neuropathies and Disorders (5 papers) and Systemic Lupus Erythematosus Research (2 papers). Virginia Devonshire is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Peripheral Neuropathies and Disorders (5 papers) and Systemic Lupus Erythematosus Research (2 papers). Virginia Devonshire collaborates with scholars based in Canada, United Kingdom and Switzerland. Virginia Devonshire's co-authors include Helen Tremlett, Donald W. Paty, Ana‐Luiza Sayao, H Grant Stiver, Peter J. Jewesson, Peter J. Zed, Fawziah Marra, Yves Lapierre, Marcelo Kremenchutzky and Virender Bhan and has published in prestigious journals such as Neurology, Journal of neurosurgery and Frontiers in Neurology.

In The Last Decade

Virginia Devonshire

10 papers receiving 528 citations

Peers

Virginia Devonshire
Jolijn J Kragt Netherlands
William T. Mayr United States
Lynn Stazzone United States
Karl Wende United States
G Rice Canada
Jolijn J Kragt Netherlands
Virginia Devonshire
Citations per year, relative to Virginia Devonshire Virginia Devonshire (= 1×) peers Jolijn J Kragt

Countries citing papers authored by Virginia Devonshire

Since Specialization
Citations

This map shows the geographic impact of Virginia Devonshire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia Devonshire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia Devonshire more than expected).

Fields of papers citing papers by Virginia Devonshire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia Devonshire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia Devonshire. The network helps show where Virginia Devonshire may publish in the future.

Co-authorship network of co-authors of Virginia Devonshire

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia Devonshire. A scholar is included among the top collaborators of Virginia Devonshire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia Devonshire. Virginia Devonshire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Roberts, Jodie I., David W. C. Hunt, Ana‐Luiza Sayao, et al.. (2025). Comparative Effectiveness of Rituximab Versus Ocrelizumab Using Real-world Evidence: A Canadian Propensity-score Matched Observational Study (P12-1.005). Neurology. 104(7_Supplement_1).
2.
Vavasour, Irene M., Roger Tam, Cornelia Laule, et al.. (2022). Cervical Spinal Cord Atrophy can be Accurately Quantified Using Head Images. Multiple Sclerosis Journal - Experimental Translational and Clinical. 8(1). 3080433960–3080433960. 6 indexed citations
3.
Woodhall, Mark, Bo Sun, Virginia Devonshire, et al.. (2021). Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort. Frontiers in Neurology. 11. 525933–525933. 13 indexed citations
4.
Lapierre, Yves, Paul O’Connor, Virginia Devonshire, et al.. (2016). Canadian Experience with Fingolimod: Adherence to Treatment and Monitoring. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 43(2). 278–283. 17 indexed citations
5.
Lapierre, Yves, et al.. (2014). Switching from Injectable Therapy Leads to High Continuation Rate on Fingolimod (P7.221). Neurology. 82(10_supplement). 1 indexed citations
6.
Selchen, Daniel, Virender Bhan, Gregg Blevins, et al.. (2012). MS, MRI, and the 2010 McDonald criteria. Neurology. 79(23_supplement_2). 21 indexed citations
7.
Sayao, Ana‐Luiza, Virginia Devonshire, & Helen Tremlett. (2007). Longitudinal follow-up of “benign” multiple sclerosis at 20 years. Neurology. 68(7). 496–500. 114 indexed citations
8.
Tremlett, Helen, Donald W. Paty, & Virginia Devonshire. (2006). Disability progression in multiple sclerosis is slower than previously reported. Neurology. 66(2). 172–177. 256 indexed citations
9.
Tremlett, Helen & Virginia Devonshire. (2006). Does the Season or Month of Birth Influence Disease Progression in Multiple Sclerosis?. Neuroepidemiology. 26(4). 195–198. 14 indexed citations
10.
Tremlett, Helen, Donald W. Paty, & Virginia Devonshire. (2005). The natural history of primary progressive MS in British Columbia, Canada. Neurology. 65(12). 1919–1923. 70 indexed citations
11.
Zed, Peter J., H Grant Stiver, Virginia Devonshire, Peter J. Jewesson, & Fawziah Marra. (2000). Continuous intrathecal pump infusion of baclofen with antibiotic drugs for treatment of pump-associated meningitis. Journal of neurosurgery. 92(2). 347–349. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026